
Milestone Pharmaceuticals MIST
€ 0.35
-5.0%
Milestone Pharmaceuticals Current Ratio | MIST
Current Ratio Jährlich Milestone Pharmaceuticals
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.58 | 1.21 | 1.29 | 9.16 | 16.5 | 24.1 | 14.7 | - | - | - | - | - | - | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 24.1 | 1.21 | 9.8 |
Current Ratio Vierteljährlich Milestone Pharmaceuticals
| 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.96 | 1.11 | 1.23 | 1.58 | 1.3 | 0.73 | 0.91 | 1.21 | 1.41 | 1.56 | 1.71 | 1.29 | 1.49 | 1.71 | 1.94 | 9.16 | 9.96 | 19.7 | 21 | 16.5 | 21 | 24.7 | 21.5 | 21.9 | 16.5 | 18.2 | 19 | 14.5 | 14.5 | 23.3 | 18.2 | 19.4 | 19.4 | 19.4 | 19.4 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Quartalsentwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 24.7 | 0.73 | 11.1 |
Current Ratio anderer Aktien in der Pharmaeinzelhändler
| Name | Current Ratio | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Histogen
HSTO
|
3.35 | - | 31.6 % | $ 2.12 M | ||
|
Checkpoint Therapeutics
CKPT
|
0.372 | - | - | $ 169 M | ||
|
Clovis Oncology
CLVS
|
0.629 | - | -7.23 % | $ 13 M | ||
|
Taro Pharmaceutical Industries Ltd.
TARO
|
5.28 | - | - | $ 1.62 B | ||
|
Omeros Corporation
OMER
|
1.87 | $ 13.23 | -5.71 % | $ 840 M | ||
|
BioLineRx Ltd.
BLRX
|
2.33 | $ 0.94 | -10.44 % | $ 2.32 B | ||
|
PhaseBio Pharmaceuticals
PHAS
|
0.394 | - | 7.4 % | $ 6.29 M | ||
|
Forma Therapeutics Holdings
FMTX
|
8.95 | - | - | $ 958 M | ||
|
Blueprint Medicines Corporation
BPMC
|
1.34 | - | - | $ 8.14 B | ||
|
Horizon Therapeutics Public Limited Company
HZNP
|
1.97 | - | - | $ 26.6 B | ||
|
Provention Bio
PRVB
|
2.06 | - | - | $ 2.37 B | ||
|
Reata Pharmaceuticals
RETA
|
1.6 | - | - | $ 6.29 B | ||
|
PainReform Ltd.
PRFX
|
4.43 | $ 0.47 | -24.53 % | $ 305 K | ||
|
iTeos Therapeutics
ITOS
|
7.11 | - | - | $ 411 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
2.76 | $ 1.44 | -2.03 % | $ 2.37 M | ||
|
PolarityTE
PTE
|
3.67 | - | -0.82 % | $ 1.78 M | ||
|
Kronos Bio
KRON
|
3.38 | - | 1.49 % | $ 50.8 M | ||
|
Cullinan Management
CGEM
|
11.3 | $ 8.9 | -1.93 % | $ 536 M | ||
|
CRISPR Therapeutics AG
CRSP
|
6.6 | $ 39.15 | 0.57 % | $ 3.52 B | ||
|
Advaxis
ADXS
|
3.37 | - | -9.65 % | $ 45.9 M | ||
|
Stoke Therapeutics
STOK
|
6.34 | $ 26.77 | -0.59 % | $ 1.59 B | ||
|
Trevena
TRVN
|
0.841 | - | -46.58 % | $ 31.8 M | ||
|
Calithera Biosciences
CALA
|
3.46 | - | -10.95 % | $ 876 K | ||
|
Molecular Templates
MTEM
|
1.14 | - | -23.43 % | $ 495 K | ||
|
Oncorus
ONCR
|
1.71 | - | -8.54 % | $ 3.19 M | ||
|
BioXcel Therapeutics
BTAI
|
0.32 | $ 0.07 | 9.81 % | $ 855 K | ||
|
Novan
NOVN
|
1.05 | - | -24.84 % | $ 2.64 M | ||
|
CohBar
CWBR
|
15.8 | - | -15.44 % | $ 2.2 M | ||
|
NeuBase Therapeutics
NBSE
|
3.48 | - | -1.56 % | $ 12.3 M | ||
|
Epizyme
EPZM
|
1.64 | - | - | $ 249 M | ||
|
Arena Pharmaceuticals
ARNA
|
10.8 | - | -6.81 % | $ 3.04 B | ||
|
Scopus BioPharma
SCPS
|
0.519 | - | -48.37 % | $ 3.71 M | ||
|
Nabriva Therapeutics plc
NBRV
|
1.12 | - | - | $ 4.55 M | ||
|
Annovis Bio
ANVS
|
4.98 | $ 0.71 | -3.81 % | $ 14.6 M | ||
|
scPharmaceuticals
SCPH
|
1.14 | - | - | $ 218 M | ||
|
Entasis Therapeutics Holdings
ETTX
|
4.22 | - | - | $ 105 M | ||
|
Athersys
ATHX
|
2.11 | - | 3.77 % | $ 22.4 M | ||
|
Global Blood Therapeutics
GBT
|
1.26 | - | - | $ 4.62 B | ||
|
Inozyme Pharma
INZY
|
1.88 | - | - | $ 207 M | ||
|
NanoString Technologies
NSTG
|
1.15 | - | -37.43 % | $ 5.1 M | ||
|
Humanigen
HGEN
|
0.193 | - | -81.12 % | $ 4.28 M | ||
|
CNS Pharmaceuticals
CNSP
|
2.1 | $ 3.56 | -9.07 % | $ 1.58 M | ||
|
Sorrento Therapeutics
SRNE
|
0.956 | - | -29.58 % | $ 126 M | ||
|
Surface Oncology
SURF
|
2.4 | - | - | $ 59.7 M | ||
|
Sierra Oncology
SRRA
|
8.18 | - | -0.05 % | $ 1.34 B | ||
|
Vaccinex
VCNX
|
0.511 | - | -61.37 % | $ 654 K | ||
|
Nymox Pharmaceutical Corporation
NYMX
|
0.088 | - | -19.68 % | $ 18.4 M | ||
|
Jounce Therapeutics
JNCE
|
7.22 | - | - | $ 98.4 M | ||
|
Cocrystal Pharma
COCP
|
2.87 | $ 0.93 | -4.11 % | $ 10.5 M | ||
|
Fortress Biotech
FBIO
|
1.5 | $ 1.89 | 6.78 % | $ 52.7 M |